Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTraws Pharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q2 2026 | 1 | -$0.72 | -$0.72 | -$0.72 |
| Q3 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2026 | 1 | -$1.05 | -$1.05 | -$1.05 |
| Q1 2027 | 1 | -$1.15 | -$1.15 | -$1.15 |
| Q2 2027 | 1 | -$1.17 | -$1.17 | -$1.17 |
| Q3 2027 | 1 | -$1.18 | -$1.18 | -$1.18 |
| Q4 2027 | 1 | -$1.21 | -$1.21 | -$1.21 |
Traws Pharma Inc. Earnings Date And Information
Traws Pharma Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.34 earnings per share for the quarter, topping analysts' consensus estimates of $-9.16 by $8.82. The company had revenue of 2.73 M for the quarter and had revenue of 226.00 K for the year. Traws Pharma Inc. has generated $-35 earnings per share over the last year ($-35.21 diluted earnings per share) and currently has a price-to-earnings ratio of -1.03. Traws Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Traws Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2025 | Q2 2025 | -$8.75 | -$0.11 | 8.64 | $60.00 K | $2.73 M |
| 12/30/2024 | Q4 2024 | N/A | -$8.81 | N/A | N/A | $57.00 K |
| 06/30/2024 | Q2 2024 | N/A | -$5.92 | N/A | $60.00 K | $56.00 K |
| 12/30/2023 | Q4 2023 | N/A | -$10.62 | N/A | N/A | $113.00 K |
| 06/30/2023 | Q2 2023 | N/A | -$11.95 | N/A | N/A | $113.00 K |
| 12/30/2022 | Q4 2022 | N/A | -$12.93 | N/A | N/A | $113.00 K |
| 06/30/2022 | Q2 2022 | -$5.31 | -$9.74 | -4.43 | N/A | $113.00 K |
| 12/30/2021 | Q4 2021 | N/A | -$9.91 | N/A | N/A | $113.00 K |
| 06/30/2021 | Q2 2021 | N/A | -$14.77 | N/A | N/A | $113.00 K |
| 12/30/2020 | Q4 2020 | N/A | -$25.91 | N/A | N/A | $123.00 K |
| 06/30/2020 | Q2 2020 | N/A | -$28.26 | N/A | N/A | $108.00 K |
| 12/30/2019 | Q4 2019 | N/A | -$299.94 | N/A | N/A | $93.00 K |
| 06/30/2019 | Q2 2019 | N/A | -$708.35 | N/A | N/A | $2.09 M |
| 12/30/2018 | Q4 2018 | N/A | -$726.91 | N/A | N/A | $179.00 K |
| 06/30/2018 | Q2 2018 | N/A | -$2,304.39 | N/A | N/A | $1.05 M |
| 12/30/2017 | Q4 2017 | N/A | -$7,267.78 | N/A | N/A | $253.00 K |
| 06/30/2017 | Q2 2017 | N/A | -$8,544.04 | N/A | N/A | $534.00 K |
| 12/30/2016 | Q4 2016 | N/A | -$6,163.76 | N/A | N/A | $1.82 M |
| 06/30/2016 | Q2 2016 | N/A | -$1,037.38 | N/A | N/A | $3.72 M |
| 12/31/2015 | Q4 2015 | N/A | -$297.31 | N/A | N/A | $11.22 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Traws Pharma Inc. Earnings: FAQ's
In the previous quarter, Traws Pharma Inc. (:TRAW) reported $-0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $-9.16 by $8.82.
The conference call for Traws Pharma Inc.'s latest earnings report can be listened to online.
The conference call transcript for Traws Pharma Inc.'s latest earnings report can be read online.
Traws Pharma Inc. (:TRAW) has a recorded annual revenue of $226.00 K.
Traws Pharma Inc. (:TRAW) has a recorded net income of $-54,674,000.Traws Pharma Inc. has generated $-35.21 earnings per share over the last four quarters.
Traws Pharma Inc. (:TRAW) has a price-to-earnings ratio of -1.03 and price/earnings-to-growth ratio is -0.03.